Hyper-CVAD
| Hyper-CVAD | |
|---|---|
| Term | Hyper-CVAD |
| Short definition | Hyper-CVAD (HY-pro .. ) An acronym for a combination chemotherapy regimen used to treat some forms of acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL). Hyper-CVAD includes the drugs cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone. This includes the drugs methotrexate and cytarabine. It is administered as hyperfractionated therapy, in which the total dose of drugs is divided into small doses and given more than once a day. Also known as Hyper-CVAD scheme |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Hyper-CVAD - (pronounced) (HY-pro . . . ) An acronym for a combination chemotherapy regimen used to treat some forms of acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL). Hyper-CVAD includes the drugs cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone. This includes the drugs methotrexate and cytarabine. It is administered as hyperfractionated therapy, in which the total dose of drugs is divided into small doses and given more than once a day. Also known as Hyper-CVAD scheme
External links
- Medical encyclopedia article on Hyper-CVAD
- Wikipedia's article - Hyper-CVAD
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski